UBS ETF Please confirm that you are resident in Germany to proceed.

ETF Comparison

UBS ETF (IE) CMCI Composite SF UCITS ETF (hedged to GBP) A-acc

ISIN IE00B50XJX92
Replication Synthetic
Asset class Commodities
Fee 0.34%

Select a fund for comparison

Name of fund

UBS (Irl) Fund Solutions plc – CMCI Composite SF UCITS ETF

Share class

UBS (Irl) Fund Solutions plc – CMCI Composite SF UCITS ETF (hedged to GBP) A-acc

ISIN

IE00B50XJX92

Asset Class

Commodities

Fund domicile

IE

Fund type

open-end

Benchmark

UBS Bloomberg CMCI® Composite GBP Monthly Hedged TR

UCITS IV

yes

Launch date

05.03.2015

Currency of share class

GBP

Accounting year end

30 June

Replication methodology

Synthetic (Fully Funded + Total Return Swap)

  • The investment objective of the fund is to deliver the performance of the UBS Bloomberg CMCI Composite Total Return. The stock exchange price may differ from the net asset value.
  • The fund synthetically replicates the index performance by investing in a swap.
  • We target to over-collateralise the funds exposure to the swap counterparty by 105%.
  • The fund is passively managed.

Flat fee p.a.

0.34%

Total expense ratio (TER) p.a.1)

0.34%

  • The UBS Bloomberg Constant Maturity Commodity Index extends beyond short dated futures contracts and diversifies investment across the maturity curve. By providing investors with access to “Constant Maturities”, it not only gives a more continuous exposure to the asset class and avoids the speculative activity that can surround monthly rolls of traditional indices, but can also minimize exposure to negative roll yield, making the index more representative of the underlying market price movements.

Please consider that this performance comparison tool serves for illustration purposes only as it allows to compare any UBS ETF regardless its fund characteristics, investment objectives. Please note that certain comparisons might be insignificant or misleading due to markets, currencies, sectors or risk exposures that might not be comparable. Neither UBS AG nor any of its affiliates, its directors, employees or agents accepts any liability for any loss or damage arising out of the use of this tool.

This publication is for your information only and is not intended as an offer or a solicitation of an offer to purchase or sell any specific products and should not be treated as giving investment advice. All information and opinions as well as any indicated prices are valid only at the time of the preparation of the information and are subject to change due to market developments any time and without prior notice. We recommend consulting an investment or tax advisor or lawyer prior to your investment. Please be aware that the products presented in this publication may not fit to the personal investment objectives, portfolio and risk profile of every individual investor.

All information and opinions expressed in this publication were obtained from sources believed to be reliable. However, no representation or warranty, expressed or implied is made to their accuracy. Please note, that UBS Deutschland AG or other companies of the UBS group (or employees thereof) may purchase or sell any financial instruments or derivatives with a corresponding underlying mentioned in this publication. Furthermore, they can act as principal respectively agent or render consulting or other services to an issuer or to companies affiliated with an issuer.

This publication is targeted neither to citizens of the United States of America or of the United Kingdom nor to any persons who have permanent residence in those jurisdictions. With regard to the products presented in this publication solely the sales brochure is legally binding which can be received from UBS Deutschland AG, P.O. Box 102042, 60020 Frankfurt/Main, upon request.

This publication may neither be altered, copied nor reproduced without the prior written consent of UBS Deutschland AG.

© UBS 2021. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.